Published in Front Mol Neurosci on July 16, 2012
The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol (2015) 1.82
The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem (2013) 1.14
Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention. Front Psychiatry (2014) 0.86
Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3. Neurobiol Aging (2014) 0.84
Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. PLoS One (2013) 0.82
The Nav1.2 channel is regulated by GSK3. Biochim Biophys Acta (2015) 0.81
Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation. Sci Rep (2015) 0.79
CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability. FASEB J (2016) 0.79
Quantitative proteomics reveals protein-protein interactions with fibroblast growth factor 12 as a component of the voltage-gated sodium channel 1.2 (nav1.2) macromolecular complex in Mammalian brain. Mol Cell Proteomics (2015) 0.79
Modulation of Kv7 channels and excitability in the brain. Cell Mol Life Sci (2016) 0.78
Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy. Oxid Med Cell Longev (2016) 0.75
Glycogen synthase kinase 3 beta alters anxiety-, depression-, and addiction-related behaviors and neuronal activity in the nucleus accumbens shell. Neuropharmacology (2017) 0.75
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Rab proteins as membrane organizers. Nat Rev Mol Cell Biol (2001) 19.95
Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol (2003) 18.97
AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci (2002) 13.09
Wnt signaling: a common theme in animal development. Genes Dev (1997) 12.94
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci (2003) 10.89
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol (2000) 9.88
The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci (2004) 7.92
GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74
The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol (2007) 6.91
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
PTC124 targets genetic disorders caused by nonsense mutations. Nature (2007) 6.67
Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J (1990) 6.23
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 6.12
Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell (2001) 6.00
Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol (2000) 5.55
Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron (2001) 5.51
International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev (2005) 5.40
Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature (2000) 5.14
Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem (1998) 5.09
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet (1998) 4.89
Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci (2000) 4.78
Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem (1980) 4.43
Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron (1999) 4.41
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 4.25
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron (2009) 4.18
Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science (2000) 4.14
Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci (2006) 4.10
Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci (2000) 4.10
A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell (2001) 4.01
Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell (2001) 3.93
CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol (2002) 3.71
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J (1993) 3.51
Voltage-gated calcium channels. Cold Spring Harb Perspect Biol (2011) 3.36
Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem (1987) 3.19
LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron (2007) 3.17
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci (2004) 3.12
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci (2000) 3.10
Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta (1992) 3.02
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature (1998) 2.96
Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci U S A (1999) 2.91
Synapsin dispersion and reclustering during synaptic activity. Nat Neurosci (2001) 2.87
Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell (2002) 2.73
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta (2009) 2.64
Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A (2006) 2.61
Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol (2009) 2.60
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci (2003) 2.54
A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron (2001) 2.48
Role of AMPA receptor endocytosis in synaptic plasticity. Nat Rev Neurosci (2001) 2.46
Functional evolutionary history of the mouse Fgf gene family. Dev Dyn (2008) 2.43
Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci U S A (1995) 2.42
Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat Neurosci (2000) 2.41
Role of beta-catenin in synaptic vesicle localization and presynaptic assembly. Neuron (2003) 2.37
Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation. J Neurosci (2007) 2.30
Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus. Nature (2002) 2.26
Rapid activity-dependent modifications in synaptic structure and function require bidirectional Wnt signaling. Neuron (2008) 2.23
Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron (2003) 2.16
NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD. Neuron (2005) 2.15
Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci (2004) 2.11
CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem (2001) 2.11
Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J Cell Sci (1998) 2.10
AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat Neurosci (2003) 2.08
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev (2003) 2.05
GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci (2011) 1.99
Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem (2006) 1.98
Biochemical interactions in the wnt pathway. Biochim Biophys Acta (2000) 1.96
The intracellular dynamic of protein palmitoylation. J Cell Biol (2010) 1.95
Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J (1990) 1.94
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A (1993) 1.92
Active dendrites, potassium channels and synaptic plasticity. Philos Trans R Soc Lond B Biol Sci (2003) 1.90
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med (2004) 1.89
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells (2005) 1.86
Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med (2002) 1.85
Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J Neurosci (2002) 1.85
Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron (2007) 1.84
Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression. J Biol Chem (2004) 1.79
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol (2002) 1.78
Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol (2000) 1.76
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A (1998) 1.75
The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci (2007) 1.74
Metaplasticity at single glutamatergic synapses. Neuron (2010) 1.74
Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem (2000) 1.73
The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci (2009) 1.73
Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol (2000) 1.68
Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development. Neuron (2011) 1.67
Bidirectional control of quantal size by synaptic activity in the hippocampus. Science (1996) 1.67
Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur J Biochem (1980) 1.65
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci (2002) 1.64
Isoform-specific modulation of voltage-gated Na(+) channels by calmodulin. Circ Res (2002) 1.62
Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology (2010) 1.61
Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol (2005) 1.56
Bulk synaptic vesicle endocytosis is rapidly triggered during strong stimulation. J Neurosci (2008) 1.55
The role of GSK-3 in synaptic plasticity. Br J Pharmacol (2008) 1.52
An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem (2009) 1.51
FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci (2009) 1.51
Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol (2005) 2.05
Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease. J Neurochem (2011) 1.56
Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem (2009) 1.56
Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14. Mol Cell Neurosci (2007) 1.40
The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem (2013) 1.14
Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex. Assay Drug Dev Technol (2012) 0.92
Peripheral adipose tissue insulin resistance alters lipid composition and function of hippocampal synapses. J Neurochem (2015) 0.86
Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. J Neurosci (2014) 0.83
Quantification of Histone Modifications by Parallel-Reaction Monitoring: A Method Validation. Anal Chem (2015) 0.81
Split-luciferase complementation assay to detect channel-protein interactions in live cells. Methods Mol Biol (2015) 0.79
Integrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology (2013) 0.79
An interview with Fernanda Laezza, MD, PhD, by Vicki Glaser. Assay Drug Dev Technol (2012) 0.75